Table 5.
Multidrugs | N (%) | Citrobacter spp. | E. coli | Klebsiella spp. | Other gram -ve | Proteus spp. | S. aureus | Strep. spp. | P value | |
---|---|---|---|---|---|---|---|---|---|---|
Amp | R1 | 98 (57.0) | 5 (71.4) | 58 (66.7) | 15 (78.9) | 11 (78.6) | 5 (83.3) | — | 4 (40.0) | <0.001 |
Amp, CL | R2 | 36 (20.9) | 5 (71.4) | 19 (21.8) | 2 (10.5) | 6 (42.9) | 4 (66.7) | — | — | <0.001 |
Amp, F | R2 | 22 (12.8) | — | 7 (8.0) | 8 (42.1) | 4 (28.6) | 3 (50.0) | — | — | <0.001 |
Amp, COT, TET | R3 | 49 (28.5) | 2 (28.6) | 32 (36.8) | 6 (31.6) | 4 (28.6) | 5 (83.3) | — | — | <0.001 |
COT, PEN, ox | R3 | 11 (6.4) | — | — | — | — | — | 11 (40.7) | — | <0.001 |
Amp, CL, TET, GEN | R4 | 16 (9.3) | 2 (28.6) | 9 (10.3) | 2 (10.5) | 1 (7.1) | 2 (33.3) | — | — | 0.122 |
Amp, CL, TET, GEN, CHL, CIP, COT, F | R8 | 4 (2.3) | — | — | 1 (5.3) | 1 (7.1) | 2 (33.3) | — | — | <0.001 |
R1: single drug resistance; R2: double drug resistance; R3-R9: multidrug resistance; Amp: ampicillin; GEN: gentamicin; COT: co-trimoxazole; ERY: erythromycin; AMK: amikacin; CAZ: ceftazidime; PEN: penicillin; TET: tetracycline; SXT: trimethoprim-sulfamethoxazole; NAL: nalidixic acid; CIP: ciprofloxacin; CHL: chloramphenicol; CL: cephalexin; CRO: ceftriaxone; F: nitrofurantoin; CD: clindamycin; ox: oxacillin; Rif: rifampicin; Van: vancomycin.